Scientists have developed a smarter way to activate the immune system against cancer, potentially making treatments safer and more precise.

Using a method called CUT&RUN, researchers saw that Zelda binds genes that decide wing shape, vein placement, and cell ...

NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

1 Department of Health Science, UniCamillus-Saint Camillus International Medical University, Rome, Italy 2 Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy ...

CBSE Class 9 Social Science Half Yearly Sample Paper for the academic year 2025-26 is an essential resource for students preparing for their mid-term examinations. This sample paper is designed to ...

The Gujranwala Board of Intermediate and Secondary Education has officially declared the Class 9th results for 2025, with over 200,000 students appearing in the annual examinations. According to the ...

Out of 314,375 registered students, 308,073 appeared in the exams. A total of 138,894 passed, putting the overall pass percentage at 45.08%. Here is a further breakdown of the Lahore Board class 9th ...

Class 9 Soical Science Syllabus 2025-2026: Social Science is a comprehensive subject which requires conceptual clarity, critical thinking, and consistent practice for securing good scores in exams.

The Punjab Boards Class 9 Result for 2025 were officially declared today, August 20, at 10:00 AM, for all nine educational boards across the province. Students can now access their matriculation ...

The CBSE has approved the introduction of open-book assessments for Class 9 students from the 2026-27 academic session. The decision follows a successful pilot study and aligns with the NEP 2020 and ...

As per the report, the CBSE's governing body approved the proposal for open book exams after a meeting held in June. The Central Board of Secondary Education (CBSE) has approved a proposal to ...

IRVING, Texas, Aug. 5, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, recently published a ...